Hybrid Closed-Loop Use Reduced Postexercise Nocturnal Hypoglycemia Tags Continuous glucose monitoring (CGM) Hybrid Closed-Loop Insulin Delivery Hypoglycemia Insulin Pumps Read more about Hybrid Closed-Loop Use Reduced Postexercise Nocturnal Hypoglycemia
Oral HRS-7535 Improved HbA1c in T2DM on Metformin Tags Hypoglycemia hBA1c GLP-1 agonists Biguanide Read more about Oral HRS-7535 Improved HbA1c in T2DM on Metformin
GLP-1RA Therapy Was Not Associated With OA Risk in T2DM Tags GLP-1 agonists Read more about GLP-1RA Therapy Was Not Associated With OA Risk in T2DM
Semaglutide Users Had Higher NAION Risk in T2DM Tags Nonarteritic Ischemic Optic Neuropathy GLP-1 agonists Read more about Semaglutide Users Had Higher NAION Risk in T2DM
Tirzepatide Outperformed Conventional Care in Early T2DM Tags GLP-1 agonists Read more about Tirzepatide Outperformed Conventional Care in Early T2DM
SGLT2 Inhibitors Lowered Liver Enzymes More Than GLP-1 RAs Tags GLP-1 agonists SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Lowered Liver Enzymes More Than GLP-1 RAs
Empagliflozin Improved Insulin Resistance More Than Sitagliptin Tags SGLT-2 Inhibitor Read more about Empagliflozin Improved Insulin Resistance More Than Sitagliptin
Experts Endorsed SGLT2i Before GLP-1 RA in CKD and T2DM Tags CKD Diabetic Nephropathy GLP-1 agonists SGLT-2 Inhibitor Read more about Experts Endorsed SGLT2i Before GLP-1 RA in CKD and T2DM
SGLT2 Inhibitors Were Linked to Lower Epilepsy Risk in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Were Linked to Lower Epilepsy Risk in T2DM
GLP-1RAs Showed Favorable Liver Outcomes Signal in T2DM Tags MASLD/MASH GLP-1 agonists Read more about GLP-1RAs Showed Favorable Liver Outcomes Signal in T2DM